Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study
30 June, 2025
The Lancet Neurology, Volume 24, Issue 7, 591 – 600
Read the articleA comparison of p-tau assays for the specificity to detect tau changes in Alzheimer’s disease
6 May, 2025
Alzheimers Dement. 2025 Apr;21(4):e70208. doi: 10.1002/alz.70208
Read the articlePlasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform
10 April, 2025
Nat Med. 2025 Apr 9. doi: 10.1038/s41591-025-03622-w. Online ahead of print. PMID: 40205199
Read the articlePlasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease
31 March, 2025
Nat Med. 2025 Mar 31. doi: 10.1038/s41591-025-03617-7. Online ahead of print. PMID: 40164726
Read the articlePlasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials
28 March, 2025
Nat Aging. 2025 Mar 28. doi: 10.1038/s43587-025-00835-z. Online ahead of print. PMID: 40155777
Read the articleMachine learning prediction of tau‐PET in Alzheimer’s disease using plasma, MRI, and clinical data
4 March, 2025
Alzheimers Dement. 2025 Feb 22;21(2):e14600. doi: 10.1002/alz.14600
Read the article